Day 3 Lunch Symposium

Title Inflammation in HIV: More Than Meets the Eyes
Details Date: 13 November 2021
Time: 13:15 to 14:15 hrs
  • To provide an overview on the changes of inflammatory markers in people living with HIV
  • To discuss the impact of antiretroviral therapy on inflammatory markers and potential implications in the development of comorbidities
Duration Session Speaker
5 min Opening Dr Chen Seong Wong
40 min Inflammation in HIV – More than meets the eye Dr Sergio Serrano-Villar
10 min Q&A session All
5 min Closing remarks Dr Chen Seong Wong
Faculty Dr Chen Seong Wong
Consultant Infectious Diseases Physician
National Centre for Infectious Diseases & Tan Tock Seng Hospital
Dr Sergio Serrano-Villar
Dr Sergio Serrano-Villar is an Infectious Diseases Physician at the University Hospital Ramón y Cajal in Madrid, Spain; and a Visiting Researcher at the University of San Francisco, California, USA.Dr Serrano-Villar is a physician-scientist who has been involved in HIV research for over 15 years. His research interests include immunopathogenesis and clinical consequences of chronic inflammation during HIV infection. Dr Serrano-Villar has also led the development of studies aimed at manipulating the microbiome in HIV-infected individuals.
Title Optimizing COVID-19 Vaccination in Asia Pacific
Details Date: 13 November 2021
Time: 13:15 to 14:15 hrs
Synopsis The objectives of this session are to discuss the public health benefits of COVID-19 vaccines and present recent advances and experience in South Africa; as well as to gain insights into the public health response, programmatic considerations, and best practices for the successful rollout of COVID-19 vaccines in differently resourced Asian settings
Objectives Learning through experience sharing, on role of microbiology in management of super infections in COVID19.
Agenda Introduction
COVID-19 Vaccination and Learnings from South Africa
Panel Discussion: COVID-19 Vaccine Roll Out in Differently Resourced Settings in Asia
Q & A

Glenda Gray, South Africa
An NRF A1 rated scientist, CEO and President of the South African Medical Research Council (SAMRC), Professor Glenda Gray is a qualified pediatrician and co-founder of the internationally recognized Perinatal HIV Research Unit in Soweto, South Africa.
Prior to her appointment at the SAMRC, she was the Executive Director of the Perinatal HIV Research Unit, an affiliate of Wits University.
Glenda’s global profile includes a role as Co-PI of the HIV Vaccine Trials Network (HVTN), a transnational collaboration for the development of HIV/AIDS prevention vaccines.
She is also Director of International Programmes for HVTN and Chairperson of the Board of the Global Alliance for Chronic Diseases, and a member of the Institute of Medicine of the National Academies, USA.
She received South Africa’s highest honour -the Order of Mapungubwe -for her pioneering research in PMTCT.
Other prestigious accolades include the Nelson Mandela Health and Human Rights Award for significant contributions in the field of mother-to-child transmission of HIV.
Selected as one of Time’s 100 Most Influential People in the World, Glenda is a recognised leader in her field.
Her qualifications include an MBBCH, FCPaeds (SA), DSc (honoris causa SFU), DSc (honoris causa SUN), LL.D (Rhodes)

Anna Lisa T. ONG-LIM, MD Philippines
Dr Ong-Lim is a Professor and Attending Pediatrician at the University of Philippines and the Philippine General Hospital (UP-PGH).
She is a fellow of the Philippine Pediatric Society, where she serves as a member of its Board of Trustees.
She is also the Immediate Past President of the Pediatric Infectious Disease Society of the Philippines.
Dr Ong-Lim received her MD from the University of the Philippines. She completed her residency in pediatrics and a post-residency fellowship in pediatric infectious disease at UP-PGH, where she is now Chief of the Division of Infectious and Tropical Disease.
As part of the Philippines’ COVID19 response effort, Dr Ong-Lim serves as a member of the DOH Technical Advisory Group, the IATF Technical Working Group on COVID 19 Variants, as well as the Interim National Immunization Technical Advisory Group for COVID 19 Vaccines.
Dr Ong-Lim has published extensively on pediatric health and infectious disease and is heavily involved in clinical trials of pediatric vaccines, including those for measles, mumps and rubella, polio, pneumococcal disease and influenza vaccines.
She is also a regular speaker on topics relating to pediatrics, infectious disease, vaccines and clinical trials in the Philippines and throughout Asia.

Young June CHOE, MD, South Korea
Dr. Young June Choe is a Clinical Assistant Professor of Pediatrics at Korea University College of Medicine and Korea University Anam Hospital.
Prior to his current position, Dr. Choe graduated with a M.D. from Seoul National University College of Medicine and obtained a Ph.D. in public health from Seoul National University School of Public Health.
He also trained as a pediatrician, subspecializing in infectious diseases at Seoul National University in Korea and the Warren Alpert Medical School at Brown University in the U.S.
Dr. Choe has served in various capacities in several public health programs in Korea, including the National Measles/Rubella Elimination Verification Committee and the National Polio Eradication Verification Committee. He has also served as a consultant and volunteer for the WHO Western Pacific Region.
Dr. Choe has authored and co-authored >80 original publications on various topics such as infectious diseases, vaccines, epidemiology, and COVID-19.
Title The glimpse of glistening solutions for MDRO infections in Asia
Details Date: November 13, 2021
Time: 13:15 – 14:15 pm (SGT)
Synopsis Multidrug-resistant organisms (MDRO) are associated with longer hospital stay, increased exposure to antimicrobial agents and excess cost. Improved treatment and management strategies are urgently needed to curb the rising burden of MDRO in Asia. In this session, we will discuss the role of rapid diagnostic testing and novel antibiotics in addressing MDRO infections, and the practical solutions to maximize health outcomes of patients without posing the risk of antimicrobial resistance in the clinic.
Objectives • To share latest data and current practice of managing MDRO infections
• To provide an interactive platform to discuss optimizing outcomes of patients with MDRO infections, from diagnosis to treatment
• To share experience on the gaps and practical challenges in managing MDRO infections and strategies to overcome these
Time Topic Faculty
13:15 Welcome and introduction Professor Balaji Veeraraghavan, India
13:17 The gold standard:
Ideal ways to manage MDRO infections and the role of novel antibiotics
Professor Tobias Welte, Germany
13:30 The other side of the story:
Current landscape and challenges in managing MDRO infections in Asia
Dr Asok Kurup, Singapore
13:40 The reality and filling the gaps – fireside chat:
Practical considerations and solutions for MDRO infections in Asia
Professor Balaji Veeraraghavan, India
Panellists: All speakers
14:05 Live Q&A All
14:13 Closing Professor Balaji Veeraraghavan, India
14:15 End
Faculty Professor Balaji Veeraraghavan, India

Balaji Veeraraghavan is Professor and Head of the Department of Clinical Microbiology, Christian Medical College and Hospital, India.

Professor Veeraraghavan is Editor-in-Chief of the Indian Journal of Medical Microbiology. He is the principal investigator for vaccine-preventable invasive bacterial disease surveillance for the World Health Organization Regional Office for South-East Asia Region and National Nodal Center for Antimicrobial Resistance Surveillance in India. He has published almost 400 peer-reviewed articles and authored the AMS Manual for the Indian Council of Medical Research. He was awarded the Global Infectious Disease Research Fellowship by National Institute of Health, and the Indo-US Science and Technology Fellowship.

Professor Tobias Welte, Germany

Tobias Welte is Professor and Head of the Department of Respiratory Medicine and Infectious Diseases at Hannover Medicinal School in Germany. He is also Directory Board Member of the Biomed Alliance and President of the Forum of International Respiratory Societies.

Professor Welte was previously President of the European Respiratory Society and German Society for Pneumology, and received the Balzan Prize for Medicine in 2019. His research focuses on the epidemiology, diagnosis and management of respiratory infections and the pathophysiology and treatment of obstructive airway disease. He has around 1,000 publications listed in Medline and has contributed to chapters in over 150 books.

Dr Asok Kurup, Singapore

Asok Kurup is Consultant with Infectious Diseases Care Pte Ltd at Mount Elizabeth Medical Centre, Singapore, and Visiting Consultant at the Department of Infectious Diseases, Singapore General Hospital. Dr Kurup is also Adjunct Associate Professor at Duke-NUS Graduate Medical School Singapore and Clinical Lecturer at National University of Singapore.

Dr Kurup is currently a committee member at the Society of Infectious Diseases and has published more than 40 papers and 70 abstracts in the field of infectious diseases.